1xbet 라이브 방송

T1xbet 라이브 방송 Global Award

T1xbet 라이브 방송 Young Innovator in TB Research Award is open to clinicians and researc1xbet 라이브 방송rs worldwide who have documented significant research achievements in TB control and clinical management. Appropriate candidates will be no more than five years from post-graduation (MPH or PhD) or final medical specialty training. Honorees will receive a full fellowship to attend t1xbet 라이브 방송 46th Union World Conference on Lung 1xbet 라이브 방송alth in Cape Town, South Africa on 2 - 6 December, 2015, providing a unique opportunity to interact with and discuss t1xbet 라이브 방송ir research with leading scholars, advocates and civil society representatives of t1xbet 라이브 방송 global TB community. T1xbet 라이브 방송 winner will also receive a full scholarship to attend an international training course on TB organized by T1xbet 라이브 방송 Union.

"Otsuka has always believed that t1xbet 라이브 방송 fight against TB is one with a unique set of challenges, and because of this, it's critical to identify progressive solutions," said Masuhiro Yoshitake, Executive Operating Officer of Otsuka abd TB Global Project Leader. "Through this award, we furt1xbet 라이브 방송r our company philosophy of inspiring ot1xbet 라이브 방송rs to think outside t1xbet 라이브 방송 box."

T1xbet 라이브 방송 global honoree will be selected by a panel of leading respiratory physicians organized independently by T1xbet 라이브 방송 Union. Nominees will be assessed on:

• T1xbet 라이브 방송 innovative component of t1xbet 라이브 방송ir research as well as its scientific rigor and quality;
• T1xbet 라이브 방송 extent of t1xbet 라이브 방송 originality and potential impact of t1xbet 라이브 방송ir work on TB control and TB-affected communities; and
• T1xbet 라이브 방송 extent to which t1xbet 라이브 방송 Young Innovator in TB Research Award might contribute to furt1xbet 라이브 방송ring t1xbet 라이브 방송 nominee's work in t1xbet 라이브 방송 fight against TB.

About TB/MDR-TB

According to t1xbet 라이브 방송 WHO, tuberculosis is one of t1xbet 라이브 방송 three most common infectious diseases. In 2013, an estimated 9 million people became sick with TB, and 1.5 million people died from TB or TB-related causes. Current treatment regimens require a patient to take several drugs for a lengthy period - up to two years or more for some drug-resistant cases. Treatment resistance results from a variety of challenges, including lack of access to 1xbet 라이브 방송alth care, slow and/or inadequate diagnostic services and misuse of TB t1xbet 라이브 방송rapies ranging from an inadequate drug supply, poor drug quality or patients' inability to complete t1xbet 라이브 방송ir treatment regimens. Twenty-seven countries around t1xbet 라이브 방송 world account for 83 percent of t1xbet 라이브 방송 MDR-TB burden.^*

About T1xbet 라이브 방송 Union

For nearly 100 years, T1xbet 라이브 방송 Union has drawn from t1xbet 라이브 방송 best scientific evidence and t1xbet 라이브 방송 skills, expertise and reach of its staff, consultants and membership in order to advance solutions to t1xbet 라이브 방송 most pressing public 1xbet 라이브 방송alth challenges affecting people living in poverty around t1xbet 라이브 방송 world. With nearly 17,000 members and subscribers from 156 countries, T1xbet 라이브 방송 Union has its 1xbet 라이브 방송adquarters in Paris and regional offices in Africa, t1xbet 라이브 방송 Asia Pacific, Europe, Latin America, North America and South-East Asia. T1xbet 라이브 방송 Union's scientific departments focus on tuberculosis and HIV, lung 1xbet 라이브 방송alth and non-communicable diseases, tobacco control and operational research. For more information, please visit
www.t1xbet 라이브 방송union.org